{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:59:58Z","timestamp":1761663598868},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T00:00:00Z","timestamp":1491523200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s10528-017-9800-2","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T11:27:50Z","timestamp":1491564470000},"page":"335-344","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Paraoxonase and Arylesterase Levels in Behcet\u2019s Disease and Their Relations with the Disease Activity"],"prefix":"10.1007","volume":"55","author":[{"given":"Ayhan","family":"Kul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hulya","family":"Uzkeser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurinnisa","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,7]]},"reference":[{"issue":"8","key":"9800_CR1","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/rheumatology\/38.8.728","volume":"38","author":"BB Bhakta","year":"1999","unstructured":"Bhakta BB, Brennan P, James TE, Chamberlain MA, Noble BA, Silman AJ (1999) Behcet\u2019s disease: evaluation of a new instrument to measure clinical activity. Rheumatology 38(8):728\u2013733","journal-title":"Rheumatology"},{"issue":"3","key":"9800_CR2","first-page":"BC01","volume":"10","author":"UD Bindal","year":"2016","unstructured":"Bindal UD, Saxena R, Siddiqui MH, Sharma D (2016) Correlation of paraoxonase status with disease activity score and systemic inflammation in rheumatoid arthritic patients. J Clin Diagn Res. 10(3):BC01\u2013BC05","journal-title":"J Clin Diagn Res."},{"issue":"10","key":"9800_CR3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1746-6148-10-74","volume":"25","author":"JJ Ceron","year":"2014","unstructured":"Ceron JJ, Tecles F, Tvarijonaviciute A (2014) Serum\u00a0paraoxonase\u00a01 (PON1) measurement: an update. BMC Vet Res. 25(10):74","journal-title":"BMC Vet Res."},{"issue":"2","key":"9800_CR4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0735-1097(00)01137-2","volume":"37","author":"JC Chambers","year":"2001","unstructured":"Chambers JC, Haskard DO, Kooner JS (2001) Vascular endothelial function and oxidative stress mechanisms in patients with Behcet\u2019s syndrome. J Am Coll Cardiol 37(2):517\u2013520","journal-title":"J Am Coll Cardiol"},{"key":"9800_CR5","doi-asserted-by":"crossref","unstructured":"Criteria for Diagnosis of Behcet\u2019s Disease. International Study Group for Behcet\u2019s Disease (1990) Lancet 335(8697):1078\u20131080","DOI":"10.1016\/0140-6736(90)92643-V"},{"issue":"43","key":"9800_CR6","doi-asserted-by":"crossref","first-page":"33435","DOI":"10.1074\/jbc.M004543200","volume":"275","author":"DI Draganov","year":"2000","unstructured":"Draganov DI, Stetson PL, Watson CE, Billecke SS, La Du BN (2000) Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation. J Biol Chem 275(43):33435\u201333442","journal-title":"J Biol Chem"},{"issue":"4","key":"9800_CR7","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.ATV.21.4.473","volume":"21","author":"PN Durrington","year":"2001","unstructured":"Durrington PN, Mackness B, Mackness MI (2001) Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 21(4):473\u2013480","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"9800_CR8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1590\/S1807-59322010000200009","volume":"65","author":"FH Erdem","year":"2010","unstructured":"Erdem FH, Karatay S, Yildirim K, Kiziltunc A (2010) Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients. Clinics 65(2):175\u2013179","journal-title":"Clinics"},{"issue":"3","key":"9800_CR9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4274\/jcrpe.1454","volume":"6","author":"E Eren","year":"2014","unstructured":"Eren E, Abuhandan M, Solmaz A, Ta\u015fk\u0131n A (2014) Serum paraoxonase\/arylesterase activity and\u00a0oxidative stress status in children with metabolicsyndrome. J Clin Res Pediatr Endocrinol. 6(3):163\u2013168","journal-title":"J Clin Res Pediatr Endocrinol."},{"issue":"2","key":"9800_CR10","first-page":"732","volume":"7","author":"MF G\u00fcrsu","year":"2002","unstructured":"G\u00fcrsu MF, \u00d6zdin M (2002) Sigara i\u00e7enlerde serum paraoksonaz (PON1) aktiviteleri ile malondialdehit d\u00fczeylerinin ara\u015ft\u0131r\u0131lmas\u0131. F\u0131rat T\u0131p Dergisi 7(2):732\u2013737","journal-title":"F\u0131rat T\u0131p Dergisi"},{"issue":"2","key":"9800_CR11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1620\/tjem.212.133","volume":"212","author":"A Isik","year":"2007","unstructured":"Isik A, Koca SS, Ustundag B, Selek S (2007) Decreased total antioxidant response and increased oxidative stress in Behcet\u2019s disease. Tohoku J Exp Med 212(2):133\u2013141","journal-title":"Tohoku J Exp Med"},{"issue":"10","key":"9800_CR12","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1136\/bjo.2004.043398","volume":"88","author":"S Karakucuk","year":"2004","unstructured":"Karakucuk S, Baskol G, Oner AO, Baskol M, Mirza E, Ustdal M (2004) Serum paraoxonase activity is decreased in the active stage of Behcet\u2019s disease. Br J Ophthalmol 88(10):1256\u20131258","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"9800_CR13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0009-9120(02)00400-9","volume":"35","author":"I Kokcam","year":"2002","unstructured":"Kokcam I, Naziroglu M (2002) Effects of vitamin E supplementation on blood antioxidants levels in patients with Behcet\u2019s disease. Clin Biochem 35(8):633\u2013639","journal-title":"Clin Biochem"},{"issue":"3","key":"9800_CR14","first-page":"375","volume":"17","author":"C Kosan","year":"2013","unstructured":"Kosan C, Cayir A, Turan MI, Ustebay S (2013) Paraoxonase 1 and arylesterase levels in children with familial Mediterranean fever. Eur Rev Med Pharmacol Sci 17(3):375\u2013378","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"9800_CR15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1620\/tjem.197.9","volume":"197","author":"K Kose","year":"2002","unstructured":"Kose K, Yazici C, Cambay N, Ascioglu O, Dogan P (2002) Lipid peroxidation and erythrocyte antioxidant enzymes in patients with Behcet\u2019s disease. Tohoku J Exp Med 197(1):9\u201316","journal-title":"Tohoku J Exp Med"},{"issue":"1\u20132","key":"9800_CR16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0378-1119(98)00193-0","volume":"213","author":"H Mochizuki","year":"1998","unstructured":"Mochizuki H, Scherer SW, Xi T, Nickle DC, Majer M, Huizenga JJ, Tsui LC, Prochazka M (1998) Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence. Gene 213(1\u20132):149\u2013157","journal-title":"Gene"},{"issue":"1","key":"9800_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.7861\/clinmedicine.17-1-71","volume":"17","author":"JR Nair","year":"2017","unstructured":"Nair JR, Moots RJ (2017) Behcet\u2019s disease. Clin Med (Lond). 17(1):71\u201377. doi: 10.7861\/clinmedicine.17-1-71","journal-title":"Clin Med (Lond)."},{"issue":"48","key":"9800_CR18","doi-asserted-by":"crossref","first-page":"44444","DOI":"10.1074\/jbc.M105660200","volume":"276","author":"CJ Ng","year":"2001","unstructured":"Ng CJ et al (2001) Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J Biol Chem 276(48):44444\u201344449","journal-title":"J Biol Chem"},{"issue":"6","key":"9800_CR19","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s00296-012-2591-1","volume":"33","author":"SM Olama","year":"2013","unstructured":"Olama SM, Elarman MM (2013) Evaluation of paraoxonase and arylesterase activities in Egyptian patients with ankylosing spondylitis. Rheumatol Int 33(6):1487\u20131494","journal-title":"Rheumatol Int"},{"issue":"2","key":"9800_CR20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1468-3083.2001.00251.x","volume":"15","author":"M Onder","year":"2001","unstructured":"Onder M, Gurer MA (2001) The multiple faces of Behcet\u2019s disease and its aetiological factors. J Eur Acad Dermatol Venereol 15(2):126\u2013136","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"9800_CR21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0009-9120(02)00290-4","volume":"35","author":"A Orem","year":"2002","unstructured":"Orem A, Yandi YE, Vanizor B, Cimsit G, Uydu HA, Malkoc M (2002) The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behcet\u2019s disease. Clin Biochem 35(3):217\u2013224","journal-title":"Clin Biochem"},{"key":"9800_CR22","unstructured":"\u00d6zdin M, G\u00fcrsu MF (2003) Koroner kalp hastalar\u0131 ile \u00e7e\u015fitli risk fakt\u00f6rlerini ta\u015f\u0131yan bireylerde paraoksonaz 1 ve arilesteraz aktiviteleri ile fenotiplerinin ara\u015ft\u0131r\u0131lmas\u0131 Uzmanl\u0131k Tezi. F\u0131rat University"},{"issue":"4","key":"9800_CR23","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/01.ATV.21.4.542","volume":"21","author":"ST Reddy","year":"2001","unstructured":"Reddy ST et al (2001) Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler Thromb Vasc Biol 21(4):542\u2013547","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"9800_CR24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00296-002-0195-x","volume":"22","author":"K Saglam","year":"2002","unstructured":"Saglam K, Serce AF, Yilmaz MI, Bulucu F, Aydin A, Akay C, Sayal A (2002) Trace elements and antioxidant enzymes in Behcet\u2019s disease. Rheumatol Int 22(3):93\u201396","journal-title":"Rheumatol Int"},{"issue":"5","key":"9800_CR25","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/00015550310003782","volume":"83","author":"R Sandikci","year":"2003","unstructured":"Sandikci R et al (2003) Lipid peroxidation and antioxidant defence system in patients with active or inactive Behcet\u2019s disease. Acta Derm Venereol 83(5):342\u2013346","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"9800_CR26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1089\/ars.2010.3774","volume":"16","author":"ZG She","year":"2012","unstructured":"She ZG, Chen HZ, Yan Y, Li H, Liu DP (2012) The human paraoxonase gene cluster as a target in the treatment of atherosclerosis. Antioxid Redox Signal 16(6):597\u2013632","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"9800_CR27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00075197-200009000-00009","volume":"3","author":"P Therond","year":"2000","unstructured":"Therond P, Bonnefont-Rousselot D, Davit-Spraul A, Conti M, Legrand A (2000) Biomarkers of oxidative stress: an analytical approach. Curr Opin Clin Nutr Metab Care 3(5):373\u2013384","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"9800_CR28","first-page":"493015","volume":"2012","author":"U T\u00fcrsen","year":"2012","unstructured":"T\u00fcrsen U (2012) Pathophysiology of the Beh\u00e7et\u2019s disease. Patholog Res Int 2012:493015","journal-title":"Patholog Res Int"},{"key":"9800_CR29","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/med\/9780199642489.001.0001","volume-title":"Oxford textbook of rheumatology","author":"RA Watts","year":"2013","unstructured":"Watts RA, Conaghan P, Denton C, Foster H, Isaacs JD, Muller-Ladner U (2013) Oxford textbook of rheumatology, 4th edn. Oxford University Press, Oxford, pp 1079\u20131162","edition":"4"},{"issue":"4","key":"9800_CR30","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.thromres.2006.02.008","volume":"119","author":"H Yapislar","year":"2007","unstructured":"Yapislar H, Aydogan S, Borlu M, Ascioglu O (2007) Decreased nitric oxide and increased platelet aggregation levels in patients with Behcet\u2019s disease. Thromb Res 119(4):461\u2013465","journal-title":"Thromb Res"},{"issue":"1","key":"9800_CR31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2133.2004.06003.x","volume":"151","author":"C Yazici","year":"2004","unstructured":"Yazici C, Kose K, Calis M, Demir M, Kirnap M, Ates F (2004) Increased advanced oxidation protein products in Behcet\u2019s disease: a new activity marker? Br J Dermatol 151(1):105\u2013111","journal-title":"Br J Dermatol"},{"issue":"3","key":"9800_CR32","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/jcp.54.3.176","volume":"54","author":"IS Young","year":"2001","unstructured":"Young IS, Woodside JV (2001) Antioxidants in health and disease. J Clin Pathol 54(3):176\u2013186","journal-title":"J Clin Pathol"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10528-017-9800-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-017-9800-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-017-9800-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T19:38:09Z","timestamp":1569008289000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10528-017-9800-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,7]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["9800"],"URL":"https:\/\/doi.org\/10.1007\/s10528-017-9800-2","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,7]]}}}